Price Move History
- Daily moves over 5%
- 48 247 sessions, October 30, 2025 to October 30, 2026
- Largest daily move
- +19.8% close of May 1, 2026
- 1-year change
- -35.5% closing prices, October 30, 2025 to October 30, 2026
- 1-month change
- -30.5% closing prices, September 30, 2026 to October 30, 2026
Company Description
KINROSS GOLD CVR 02/24/32 (KGCRF) represents an investment security linked to Kinross Gold Corporation. Available information associates this security with Kinross Gold Corporation, a foreign issuer that files reports with the U.S. Securities and Exchange Commission (SEC) under cover of Form 40-F and Form 6-K. These filings indicate that Kinross Gold Corporation provides regular disclosures to investors as a foreign private issuer.
According to multiple Form 6-K filings, Kinross Gold Corporation files current reports to furnish press releases, financial statements, and related certifications. The company furnishes unaudited interim condensed consolidated financial statements and Management’s Discussion and Analysis for specific periods, and it incorporates certain 6-K filings by reference into its Registration Statements on Form S-8. These practices show that Kinross Gold Corporation uses SEC filings to communicate financial information and corporate actions to the market.
Form 6-K filings for Kinross Gold Corporation describe events such as a rating upgrade by Moody’s, the early redemption of Senior Notes, the declaration of dividends, and the sale of a portion of shares held in another company. They also reference CEO and CFO certifications of interim filings. This pattern of disclosures highlights the types of corporate and capital markets activities that may be relevant to holders of securities tied to Kinross Gold Corporation, including the KINROSS GOLD CVR 02/24/32.
Kinross Gold Corporation is identified in the filings as having its principal executive office in Toronto, Ontario, Canada. As a foreign issuer furnishing Form 6-K and filing annual reports under cover of Form 40-F, it follows the Canadian disclosure framework while also providing information to U.S. investors through the SEC’s EDGAR system. The KGCRF security is therefore connected to a company that maintains an ongoing presence in cross-border public markets through these regulatory filings.
Because the available data focuses on Kinross Gold Corporation’s SEC reporting rather than detailed terms of the KINROSS GOLD CVR 02/24/32 itself, investors often look to the company’s current reports, financial statements, and press releases for context on how broader corporate actions may relate to their securities. The repeated use of Form 6-K to furnish press releases and financial information underscores the role of regulatory filings as a primary information source for market participants following KGCRF.
Kinross Gold Corporation in SEC Filings
Kinross Gold Corporation’s Form 6-K filings show that it uses these reports to provide:
- Press releases describing corporate events, such as a rating upgrade by Moody’s and the early redemption of Senior Notes.
- Press releases announcing unaudited results for specific quarters, dividend declarations, and redemptions of Senior Notes.
- Unaudited interim condensed consolidated financial statements and Management’s Discussion and Analysis for particular periods.
- CEO and CFO certifications of interim filings.
- Notices regarding the sale of a portion of shares held in another company.
These filings are sometimes expressly incorporated by reference into Registration Statements on Form S-8, indicating that Kinross Gold Corporation links its current disclosures to existing registration documents for securities-related purposes.
Regulatory Context for KGCRF
The KINROSS GOLD CVR 02/24/32 (KGCRF) is associated by name with Kinross Gold Corporation, whose ongoing SEC reporting activity provides a regulatory backdrop for this security. Form 6-K filings demonstrate that Kinross Gold Corporation communicates financial and corporate developments to investors through press releases and interim financial reports furnished to the SEC. For investors researching KGCRF, these filings can help illustrate the types of events and disclosures that may be relevant when evaluating securities connected to Kinross Gold Corporation.
Stock Performance
Kinross Gold CVR 02/24/32 (KGCRF) closed at $0.8260 on October 30, 2026. Over the past 12 months, the price has lost 35.5%.
KGCRF Metrics & Rankings
Price returns through October 30, 2026. Month and year figures include the first trading day. Ranking links may use different dates.
Latest News
SEC Filings
Kinross Gold CVR 02/24/32 has filed 10 recent SEC filings, including 10 Form 6-K. The most recent filing was submitted on . SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all KGCRF SEC filings →
Financial Highlights
Kinross Gold CVR 02/24/32 generated $7.1B in revenue in FY2025, retaining a 52.7% gross margin, operating income reached $3.3B (46.5% operating margin), and net income was $2.4B, reflecting a 33.9% net profit margin. Diluted earnings per share stood at $1.95. The company generated $3.8B in operating cash flow. The current ratio was 2.35, measuring current assets divided by current liabilities.
Upcoming Events
Short Interest History
Short interest in Kinross Gold CVR 02/24/32 (KGCRF) currently stands at 120.2 thousand shares, representing 0.0% of the shares outstanding. Since November 2025, short interest has decreased by 59.1%.
Days to Cover History
Days to cover for Kinross Gold CVR 02/24/32 (KGCRF) currently stands at 1.0 days, down 88.6% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Across the settlements charted above, it has ranged from 1.0 to 10.9 days.
KGCRF Company Profile & Sector Positioning
Kinross Gold CVR 02/24/32 (KGCRF) and is listed on the OTC.
Investors comparing KGCRF often look at related companies in the same sector, including Enbridge CUM Pref SR 1 (EBBGF), Sunrise Communications A (SNNRF), Vertical Aerospce Ltd WTS (EVTWF), Calidi Biotherputics WTS (CLDWW), and Ligand Pharms Beta CVR (LGNZZ). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate KGCRF's relative position within its industry.